Kosasa Thomas purchased $750K of ONMD

Kosasa Thomas purchased 129,758 shares of OneMedNet Corp (ONMD) at $5.78 ($0.75M total) on 2026-10-07.

Original reporting
SEC EDGAR · Kosasa Thomas
Published Oct 14, 2026, 12:32 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 14, 2026, 1:05 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ONMD
Bullish
medium confidence
Mentioned
$ONMD
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ONMDBullishLow
01

Why it matters

The transaction adds to the insider's stake, possibly indicating confidence, but the amount is modest relative to market cap.

02

Market read

Primary relevance is to ONMD shareholders; broader market impact is limited.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed.

Relevance 6/10Novelty 4/10Timing: after filing today

Background

SEC Form 4 filing discloses an insider purchase by a director and 10% owner.

Company-level read

Ticker impact

$ONMDBullishMedium confidence
Context

Director and 10% owner Kosasa Thomas purchased 129,758 shares at $5.78, raising holdings to 1,983,573 shares.

Expected impact

likely slight upward pressure as market prices in insider confidence

Evidence & confidence

The purchase is sizable for a micro‑cap and signals confidence from a major shareholder.

Market effects

Minimal impact on the broader telehealth sector.

No significant regional effect.

Limited to investors tracking insider activity.

Counterpoint

The purchase could be a routine portfolio rebalancing rather than a bullish signal.

Key entities

  • OneMedNet Corp

    US‑listed telehealth platform (ticker ONMD).

  • Kosasa Thomas

    Director and 10% owner of OneMedNet.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ONMDLow

OneMedNet Reports Preliminary Revenue for Third Quarter 2026 and Fourth Quarter 2026 Outlook

OneMedNet Corp (ONMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE OneMedNet Reports Preliminary Revenue for Third Quarter 2026 and Fourth Quarter 2026 Outlook MINNEAPOLIS, NOVEMBER 6, 2026 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provi